Evidence map›Paper›PMID 28869755›Full record

ArticleNature methods2017

Sampling strategies to capture single-cell heterogeneity.

Satwik Rajaram, Louise E Heinrich, John D Gordan, Jayant Avva, Kathy M Bonness, Agnieszka K Witkiewicz, James S Malter, Chloe E Atreya, Robert S Warren, Lani F Wu and 1 more

Abstract read
In one paragraph

Article in Nature methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Collective gradient sensing and chemotaxis: modeling and recent developments.Journal of physics. Condensed matter : an Institute of Physics journal · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Satwik RajaramDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0001-8242-4402
Louise E HeinrichDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-4394-922X
John D GordanDepartment of Medicine, University of California, San Francisco, San Francisco, California, USA.
Jayant AvvaGreen Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kathy M BonnessGreen Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Agnieszka K WitkiewiczDepartment of Pathology, University of Arizona, Tucson, Arizona, USA.
James S MalterDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Chloe E AtreyaDepartment of Medicine, University of California, San Francisco, San Francisco, California, USA.
Robert S WarrenHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.
Lani F WuDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
Steven J AltschulerDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0001-9142-0796

Funding

Thr Role of Pin1 in AirwayP01HL088594 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI JARJOUR, NIZAR N · 2008 to 2017
$21.0M
Maximizing the predictive power of high-throughput, microscopy-based phenotypic screensR01CA184984 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WU, LANI F · 2014 to 2025
$4.7M
Lung cancer heterogeneity and its impact on drug resistance.R01CA133253 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ALTSCHULER, STEVEN J · 2010 to 2015
$2.3M
(PQD1) An Iterative Approach for Overcoming Evolving Targeted Therapy ResistanceR01CA185404 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WU, LANI F · 2014 to 2017
$1.3M
Systems-level role of GSK3 in colonic epithelium homeostasis and drug resistanceR01GM112690 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALTSCHULER, STEVEN J · 2015 to 2018
$1.3M
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer ModelsK08CA175153 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ATREYA, CHLOE E. · 2013 to 2017
$867k
PULMONARY HEMODYNAMICSR01HL019298 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GORDON, JOHN BERNARD · 1985 to 2007
$775k
NCI NIH HHS K08 CA175153NCI NIH HHS R01 CA133253NCI NIH HHS R01 CA184984NCI NIH HHS R01 CA185404NHLBI NIH HHS P01 HL088594NHLBI NIH HHS R01 HL019298NIGMS NIH HHS R01 GM112690
6 · The paper itself

Abstract

Advances in single-cell technologies have highlighted the prevalence and biological significance of cellular heterogeneity. A critical question researchers face is how to design experiments that faithfully capture the true range of heterogeneity from samples of cellular populations. Here we develop a data-driven approach, illustrated in the context of image data, that estimates the sampling depth required for prospective investigations of single-cell heterogeneity from an existing collection of samples.

Indexed as

AdenocarcinomaBiomarkers, TumorCarcinoma, Non-Small-Cell LungCell Culture TechniquesCell LineGene Expression Regulation, NeoplasticHumansLung NeoplasmsSingle-Cell AnalysisBiomarkers, Tumor

Identifiers

PMID28869755
PMCPMC5658002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.